Abeona Therapeutics Inc. (ABEO)

NASDAQ: ABEO · Real-Time Price · USD

5.12

+0.08 (1.59%)

At close: Feb 18, 2026, 4:00 PM EST

5.06

-0.06 (-1.17%)

After-hours: Feb 18, 2026, 6:25 PM EST

Abeona Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	0.4	-	3.5	1.41	3	10
Revenue Growth (YoY)	-	-	147.53%	-52.87%	-70.00%	-
Cost of Revenue	29.68	34.36	32.7	29.42	38.73	30.14
Gross Profit	-29.28	-34.36	-29.2	-28	-35.73	-20.14
Selling, General & Admin	53.93	29.85	19	17.26	21.64	23.78
Operating Expenses	53.93	29.85	19	17.26	21.64	28.37
Operating Income	-83.21	-64.21	-48.2	-45.26	-57.37	-48.5
Interest Expense	-3.94	-4.21	-0.42	-0.74	-3.66	-4.12
Interest & Investment Income	5.03	4.25	2.12	0.43	0.04	1.3
Other Non Operating Income (Expenses)	12.41	0.44	-8.71	11.66	0.02	-
EBT Excluding Unusual Items	-69.7	-63.74	-55.21	-33.9	-60.97	-51.32
Impairment of Goodwill	-	-	-	-	-32.47	-
Gain (Loss) on Sale of Assets	152.37	0	-0.05	-0.14	-	-
Asset Writedown	-	-	1.07	-5.66	-	-32.92
Other Unusual Items	-	-	-	-	8.5	-
Pretax Income	82.67	-63.73	-54.19	-39.7	-84.94	-84.23
Net Income	82.35	-63.73	-54.19	-39.7	-84.94	-84.23
Preferred Dividends & Other Adjustments	-	-	-	3.78	-	-
Net Income to Common	82.35	-63.73	-54.19	-43.48	-84.94	-84.23
Shares Outstanding (Basic)	51	41	21	8	4	4
Shares Outstanding (Diluted)	62	41	21	8	4	4
Shares Change (YoY)	74.23%	91.99%	171.96%	99.65%	6.24%	84.02%
EPS (Basic)	1.60	-1.55	-2.53	-5.53	-21.57	-22.73
EPS (Diluted)	1.29	-1.55	-2.53	-5.53	-21.57	-22.73
Free Cash Flow	-82.36	-58.46	-37.34	-43.61	-69.82	-36.36
Free Cash Flow Per Share	-1.34	-1.42	-1.75	-5.55	-17.73	-9.81
Gross Margin	-	-	-	-	-	-201.39%
Operating Margin	-20802.25%	-	-1377.14%	-3200.64%	-1912.33%	-485.04%
Profit Margin	20587.50%	-	-1548.23%	-3074.82%	-2831.20%	-842.34%
Free Cash Flow Margin	-20590.00%	-	-1066.86%	-3084.37%	-2327.20%	-363.55%
EBITDA	-80.98	-62.21	-45.91	-42.16	-54.12	-43.92
D&A For EBITDA	2.23	2	2.29	3.09	3.25	4.59
EBIT	-83.21	-64.21	-48.2	-45.26	-57.37	-48.5
Revenue as Reported	-	-	-	-	-	10

Updated Nov 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q